Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome set

Autor: N. A. M. Cooper, C. Rivas, M. G. Munro, H. O. D. Critchley, T. J. Clark, K. A. Matteson, R. Papadantonaki, S. Yorke, A. Tan, M. Bofill Rodriguez, M. Bongers, A. Al‐Hendy, L. Bahamondes, A. Connolly, C. Farquhar, T. Gray Valbrun, M. Hickey, H. S. Taylor, D. Toub, S. Vannuccini, S. Iliodromiti, K. Khan

Publikováno v: Cooper, N A M, Rivas, C, Munro, M G, Critchley, H O D, Clark, T J, Matteson, K A, Papadantonaki, R, Yorke, S, Tan, A, Bofill rodriguez, M, Bongers, M, Al-hendy, A, Bahamondes, L, Connolly, A, Farquhar, C, Gray valbrun, T, Hickey, M, Taylor, H S, Toub, D, Vannuccini, S, Iliodromiti, S & Khan, K 2023, ' Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome set ', BJOG: An International Journal of Obstetrics and Gynaecology . https://doi.org/10.1111/1471-0528.17473

Objective: To develop a core outcome set for heavy menstrual bleeding (HMB). Design: Core outcome set (COS) development methodology described by the COMET initiative. Setting: University hospital gynaecology department, online international survey an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03f44216f35d70c438fa3ba5a027895b
https://hdl.handle.net/20.500.11820/86915f78-a872-43eb-b143-c20f64e50588

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Reference values of thrombolastometry parameters in healthy term neonates

Autor: Theodoraki, M. Sokou, R. Valsami, S. Iliodromiti, Z. Pouliakis, A. Parastatidou, S. Karavana, G. Ioakeimidis, G. Georgiadou, P. Iacovidou, N. Boutsikou, T.

Background: Thromboelastometry (ROTEM), as a point of care test, is an attractive tool for rapid evaluation of hemostasis. Currently, no reference ranges exist for all ROTEM assays in neonates, limiting its use in this vulnerable population. The aim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::cfd2dc00b37dcdd165fd07b75323efd2
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103395

Fetuin A Concentration in the Second Trimester Amniotic Fluid of Fetuses with Trisomy 21 Appears to Be Lower: Phenotypic Considerations

Autor: S. Iliodromiti, N. Vrachnis, Evangelia Samoli, Z. Iliodromiti, C. Pangalos, N. Drakoulis, G. Creatsas, D. Botsis

Publikováno v: Mediators of Inflammation, Vol 2012 (2012)

Objective. We investigated whether the concentration of the glycoprotein fetuin A is altered in the second trimester amniotic fluid of trisomy 21 pregnancies compared with euploid pregnancies. Methods. 25 pregnancies with an extra chromosome 21 were

Externí odkaz: https://doaj.org/article/932269b118c7494eb2b0f7999badb127